Literature DB >> 4567074

Spina bifida cystica. Results of treatment of 270 consecutive cases with criteria for selection for the future.

J Lorber.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 4567074      PMCID: PMC1648403          DOI: 10.1136/adc.47.256.854

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  37 in total

1.  Nalidixic acid in chronic urinary-tract infections in children.

Authors:  J Lorber
Journal:  Practitioner       Date:  1967-05

2.  Ethical and social aspects of treatment of spina bifida.

Authors:  R B Zachary
Journal:  Lancet       Date:  1968-08-03       Impact factor: 79.321

3.  Ethical and social aspects of treatment of spina bifida.

Authors:  R M Forrester
Journal:  Lancet       Date:  1968-11-09       Impact factor: 79.321

4.  Ethical and social aspects of treatment of spina bifida.

Authors:  I G Wickes
Journal:  Lancet       Date:  1968-09-21       Impact factor: 79.321

5.  The management of deformity and paralysis of the foot in myelomeningocele.

Authors:  W J Sharrard; I Grosfield
Journal:  J Bone Joint Surg Br       Date:  1968-08

6.  Surgical treatment of myelomeningocele.

Authors:  D D Matson
Journal:  Pediatrics       Date:  1968-08       Impact factor: 7.124

7.  Operative management of the neurogenic bladder in children: diversion through intestinal conduits.

Authors:  R C Cook; J Lister; R B Zachary
Journal:  Surgery       Date:  1968-05       Impact factor: 3.982

8.  Early closure of myelomeningocele, with special reference to leg movement.

Authors:  G Brocklehurst; J R Gleave; W Lewin
Journal:  Br Med J       Date:  1967-03-18

9.  Spina bifida cystica and family stress.

Authors:  E H Hare; K M Laurence; H Payne; K Rawnsley
Journal:  Br Med J       Date:  1966-09-24

10.  Recovery of vision following prolonged blindness in children with hydrocephalus or following pyogenic meningitis.

Authors:  J Lorber
Journal:  Clin Pediatr (Phila)       Date:  1967-12       Impact factor: 1.168

View more
  29 in total

1.  Spina bifida children attending ordinary schools.

Authors:  H Welbourn
Journal:  Br Med J       Date:  1975-01-18

2.  Long-term outcome in open spina bifida.

Authors:  Pippa Oakeshott; Gillian M Hunt
Journal:  Br J Gen Pract       Date:  2003-08       Impact factor: 5.386

3.  The development of a lifetime care model in comprehensive spina bifida care.

Authors:  Betsy Hopson; Brandon G Rocque; David B Joseph; Danielle Powell; Amie B Jackson McLain; Richard D Davis; Tracey S Wilson; Michael J Conklin; Jeffrey P Blount
Journal:  J Pediatr Rehabil Med       Date:  2018

4.  Perineal sensation: an important predictor of long-term outcome in open spina bifida.

Authors:  P Oakeshott; G M Hunt; R H Whitaker; S Kerry
Journal:  Arch Dis Child       Date:  2006-08-30       Impact factor: 3.791

5.  Incidence of normal micturition in myelomeningocele patients.

Authors:  I Reiner; M Jones; S Donnell; A M Rickwood
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

6.  Quality of life in spina bifida: importance of parental hope.

Authors:  H M Kirpalani; P C Parkin; A R Willan; D L Fehlings; P L Rosenbaum; D King; A J Van Nie
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

7.  Urinary continence in open myelomeningocele.

Authors:  R J Brereton; R B Zachary; J Lister
Journal:  Arch Dis Child       Date:  1977-09       Impact factor: 3.791

8.  Shunt placement and myelomeningocele repair: simultaneous vs sequential shunting. Review of 12 cases.

Authors:  N E Epstein; A D Rosenthal; J Zito; M Osipoff
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

9.  Prenatal diagnosis and management of fetal hydrocephaly and lissencephaly.

Authors:  W Holzgreve; R Feil; F Louwen; P Miny
Journal:  Childs Nerv Syst       Date:  1993-11       Impact factor: 1.475

10.  Predictive factors in open myelomeningocele with special reference to sensory level.

Authors:  G Hunt; W Lewin; J Gleave; D Gairdner
Journal:  Br Med J       Date:  1973-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.